Skip to main content
Caplight Logo









Noxware

Noxware

Private
TorontoHealthcare & Life Scienceshttps://noxware.ca/

Last Round

Pre Seed

Aug 4, 2022

Total Funding Raised

$30,000

Company Overview

Noxware operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Pre Seed round in August 2022.

Noxware is a monitoring equipment company that provides solutions for preventing pressure-related injuries such as bed sores.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Noxware Comparables

Compare Noxware with similar companies based on industry and business-model similarity.

Noxware comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Curiato Inc.
87%
Sensoria Health
77%
XSENSOR Technology Corporation
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Noxware Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 4, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Noxware Investors

Notable investors and investment history

Noxware investors
InvestorRounds
Treefrog AcceleratorPre Seed
i.d.e.a. FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 4, 2022

    $30K round from i.d.e.a. Fund and Treefrog Accelerator

Book a demo to see all signals

For institutional investors. Book with your work email.

Noxware Filings

Explore SEC and related filing metadata, where available.

Noxware filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Noxware's valuation, stock price, and market status.

Is Noxware a public or private company?

Noxware is a private company.

What is the current stock price of Noxware?

Noxware is a private company, so its shares have no public market price. Caplight tracks Noxware's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Noxware worth (valuation)?

Valuation information for Noxware is not publicly available.

Can I buy Noxware stock?

Noxware shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Noxware's last funding round?

Noxware's most recent funding round was Pre Seed on August 4, 2022.

Who are the main investors in Noxware?

Key investors in Noxware include Treefrog Accelerator, i.d.e.a. Fund.

Will Noxware IPO soon?

No public IPO plans have been announced for Noxware.

How can I track Noxware secondary market activity?

Caplight tracks bids, offers, and trades in Noxware's shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range1
Year Founded2020
Last FundingAug 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?